FindTrial
Sign In

Intravenous lidocaine in video-assisted thoracic surgery for non-small cell lung cancer: a randomized, double-blind, placebo-controlled trial

Effect of intravenous lidocaine on serum level of IL-17 after video-assisted thoracic surgery for non-small cell lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030629
Enrollment
Unknown
Registered
2020-03-08
Start date
2020-03-12
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer surgery and anesthesia

Interventions

Lidocaine group:Intravenous infusion of lidocaine
Control group:Intravenous infusion of the same amount of normal saline

Sponsors

Taicang First People's Hospital, Taicang Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 67 Years

Inclusion criteria

Inclusion criteria: Patients aged >= 18 years with ASA physical status I–III scheduled for elective VATS procedures for early-stage NSCLC.

Exclusion criteria

Exclusion criteria: Severe cardiac, pulmonary, renal, or liver dysfunction, second- or third-degree atrioventricular block, neuropsychiatric disorders, immune system disease, allergy to local anesthetics, or history of chemotherapy.

Design outcomes

Primary

MeasureTime frame
serum IL-17;—

Secondary

MeasureTime frame
serum IL-17;serum COR;VAS pain scores;incidence of PONV;incidence of dizziness;incidence of arrhythmia;30-day mortality;—

Countries

China

Contacts

Public ContactWencheng Shi

Department of Anesthesiology, Taicang First People's Hospital

shiwen3333@sina.com+86 13962622920

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026